Cell Line : NCI-H929
Cellosaurus Index : CVCL_1600
Cellosaurus ID : NCI-H929
CCLE Name
: NCIH929_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
CTRP2 Name
: NCIH929
GDSC1 Name
, GDSC2 Name
: NCI-H929
Cancer Type : haematopoietic_and_lymphoid_tissue
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| NCI-H929 | (5Z)-7-Oxozeaenol | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | 123138 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H929 | 123829 | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H929 | 150412 | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H929 | 16-beta-bromoandrosterone | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H929 | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | 3-Cl-AHPC | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | 5-azacytidine | GDSC2 | 0.0200 | 20.0000 |
|
| NCI-H929 | 5-Fluorouracil | GDSC2 | 0.0200 | 32.0000 |
|
| NCI-H929 | 50869 | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H929 | 615590 | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H929 | 630600 | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H929 | 667880 | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H929 | 720427 | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H929 | 729189 | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H929 | 741909 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H929 | 743380 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H929 | 765771 | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H929 | 776928 | GDSC2 | 0.0300 | 30.0000 |
|
| NCI-H929 | 965-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | 968 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | 993-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | A-366 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | AA-COCF3 | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H929 | ABT737 | GDSC2,CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H929 | AC55649 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | Acetalax | GDSC2 | 0.0300 | 30.0000 |
|
| NCI-H929 | Afatinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Afuresertib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | AGI-5198 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | AGI-6780 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | AGK-2 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | AICA Ribonucleotide | GDSC1 | 7.8125 | 2000.0000 |
|
| NCI-H929 | Alisertib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | alisertib:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H929 | Alpelisib | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H929 | alpha-lipoic acid | GDSC2 | 0.1211 | 121.0000 |
|
| NCI-H929 | AM-580 | CTRP2 | 0.0160 | 530.0000 |
|
| NCI-H929 | AMG-319 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | ascorbate (vitamin C) | GDSC2 | 2.0011 | 2000.0000 |
|
| NCI-H929 | ASN 05257430 | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H929 | AT13148 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | AT7867 | CTRP2 | 0.0020 | 33.0000 |
|
| NCI-H929 | austocystin D | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H929 | Avagacestat | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | Axitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | AZ-3146 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | AZ20 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | AZ6102 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | AZ960 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | azacitidine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | AZD1208 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | AZD1332 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | AZD1480 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H929 | AZD2014 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | AZD3514 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | AZD3759 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H929 | AZD4547 | GDSC1,GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| NCI-H929 | AZD4877 | GDSC1 | 0.0002 | 0.0390 |
|
| NCI-H929 | AZD5153 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | AZD5363 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | AZD5438 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | AZD5582 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | AZD5991 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | AZD6094 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H929 | AZD6482 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | AZD6738 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | AZD7762 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | AZD7969 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | AZD8055 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | AZD8186 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| NCI-H929 | AZD8835 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | AZD8931 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | barasertib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | bardoxolone methyl | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BAY ACCi | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | BAY AKT1 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | BAY-HDAC11_1 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | BAY-HDAC11_2 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | BAY-HDAC11_4 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | BAY-MPS-combo 2 (paclitaxel 1 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| NCI-H929 | BAY-MPS-combo-1 (paclitaxel 5 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| NCI-H929 | BAY-MPS1 | GDSC1 | 0.0117 | 3.0000 |
|
| NCI-H929 | BDF00022089a | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H929 | BDILV000379a | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H929 | BDOCA000347a | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H929 | BDP-00009066 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | BEC | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H929 | BEN | GDSC2 | 0.0300 | 30.0000 |
|
| NCI-H929 | bendamustine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | betulinic acid | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Bexarotene | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BI-2536 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | BIBR-1532 | GDSC2,CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H929 | Bicalutamide | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BIX-01294 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | Bleomycin | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H929 | Bleomycin (10 uM) | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | Bleomycin (50 uM) | GDSC1,GDSC2 | 0.0400 | 50.0000 |
|
| NCI-H929 | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BMS-195614 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BMS-270394 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BMS-345541 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BMS-536924 | GDSC1,GDSC2,CTRP2 | 0.0011 | 18.0000 |
|
| NCI-H929 | BMS-754807 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | Bortezomib | GDSC2,CTRP2 | 0.0000 | 0.1300 |
|
| NCI-H929 | Bosutinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BPD-00008900 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | BPTES | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | BRD-A02303741 | CTRP2 | 0.0017 | 55.0000 |
|
| NCI-H929 | BRD-A02303741:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 4.2000 |
|
| NCI-H929 | BRD-A71883111 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | BRD-A94377914 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | BRD-K02251932 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K02492147 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K03536150 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K03911514 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K04800985 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K07442505 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K09587429 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K11533227 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K13185470 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K13999467 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K14844214 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K16130065 | CTRP2 | 0.0020 | 8.3000 |
|
| NCI-H929 | BRD-K16147474 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K17060750 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K19103580 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K20514654 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K24690302 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K26531177 | CTRP2 | 0.0100 | 83.0000 |
|
| NCI-H929 | BRD-K27188169 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K27188169:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H929 | BRD-K27224038 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K27986637 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K28456706 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K29086754 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K29313308 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K30019337 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K33199242 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K34099515 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K34222889 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K34485477 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | BRD-K35604418 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K37390332 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | BRD-K41334119 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K41597374 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K44224150 | CTRP2 | 0.0010 | 34.0000 |
|
| NCI-H929 | BRD-K45681478 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K48334597 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K49290616 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K50799972 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K55116708 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K58730230 | CTRP2 | 0.0020 | 33.0000 |
|
| NCI-H929 | BRD-K61166597 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K63431240 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K64610608 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | BRD-K66453893 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K66532283 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K70511574 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K71781559 | CTRP2 | 0.0041 | 66.0000 |
|
| NCI-H929 | BRD-K75293299 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K78574327 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K79669418 | CTRP2 | 0.0020 | 33.0000 |
|
| NCI-H929 | BRD-K80183349 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K84807411 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K85133207 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K86535717 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K88742110 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K96431673 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K96970199 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K97651142 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD-K99584050 | CTRP2 | 0.0020 | 33.0000 |
|
| NCI-H929 | BRD1812 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD1835 | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H929 | BRD4132 | CTRP2 | 0.0049 | 160.0000 |
|
| NCI-H929 | BRD4770 | CTRP2 | 0.0010 | 17.0000 |
|
| NCI-H929 | BRD55319 | CTRP2 | 0.0011 | 18.0000 |
|
| NCI-H929 | BRD6340 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | BRD6430 | CTRP2 | 0.0020 | 33.0000 |
|
| NCI-H929 | BRD8899 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | BRD8958 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | BRD9647 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | BRD9876 | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H929 | brefeldin A | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H929 | brivanib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Bromosporine | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H929 | Buparlisib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | BX795 | GDSC1 | 0.0195 | 5.0000 |
|
| NCI-H929 | C6-ceramide | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Cabozantinib | CTRP2 | 0.0320 | 66.0000 |
|
| NCI-H929 | Camptothecin | GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H929 | canertinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Capivasertib | GDSC1 | 0.1172 | 30.0000 |
|
| NCI-H929 | Carboplatin | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | carboplatin:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H929 | Carmustine | GDSC2 | 0.0300 | 30.0000 |
|
| NCI-H929 | CAY10576 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | CAY10594 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | CCT-018159 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | CCT007093 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | CCT036477 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | CCT245232 | GDSC1 | 0.0008 | 0.2000 |
|
| NCI-H929 | CCT245467 | GDSC1 | 0.0008 | 0.2000 |
|
| NCI-H929 | CD-1530 | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H929 | CD-437 | CTRP2 | 0.0011 | 18.0000 |
|
| NCI-H929 | CDK9_5038 | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H929 | CDK9_5576 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | Cediranib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | ceranib-2 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | cerulenin | CTRP2 | 0.0045 | 150.0000 |
|
| NCI-H929 | Cetuximab | GDSC1 | 0.2570 | 65.8000 |
|
| NCI-H929 | Ch-55 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | CHEMBL1222381 | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H929 | CHEMBL374350 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | CHIR-99021 | GDSC1,CTRP2 | 0.0024 | 80.0000 |
|
| NCI-H929 | chlorambucil | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H929 | CHM-1 | CTRP2 | 0.0005 | 16.0000 |
|
| NCI-H929 | CI-1040 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | CI-976 | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H929 | ciclopirox | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | ciclosporin | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | CIL41 | CTRP2 | 0.0049 | 160.0000 |
|
| NCI-H929 | CIL55 | CTRP2 | 0.0003 | 10.0000 |
|
| NCI-H929 | CIL55A | CTRP2 | 0.0024 | 80.0000 |
|
| NCI-H929 | CIL56 | CTRP2 | 0.0001 | 2.5000 |
|
| NCI-H929 | CIL70 | CTRP2 | 0.0012 | 40.0000 |
|
| NCI-H929 | cimetidine | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H929 | Cisplatin | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| NCI-H929 | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Compound 1541A | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H929 | compound 1B | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Compound 23 citrate | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | Compound 7d-cis | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | CPI-637 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | CR-1-31B | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | Crizotinib | GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| NCI-H929 | crizotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0030 | 50.0000 |
|
| NCI-H929 | CRT0105446 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | CRT0105950 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | CRT0160829 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H929 | CT7033-2 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | curcumin | CTRP2 | 0.0051 | 170.0000 |
|
| NCI-H929 | cyanoquinoline 11 | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H929 | Cyclophosphamide | GDSC2,CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H929 | Cytarabine | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H929 | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | cytochalasin B | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | CZC24832 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | Dabrafenib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | Dacarbazine | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Dactinomycin | GDSC2 | 0.0000 | 0.8000 |
|
| NCI-H929 | Dactolisib | GDSC1,GDSC2 | 0.0003 | 0.2500 |
|
| NCI-H929 | Daporinad | GDSC1,GDSC2 | 0.0001 | 1.0000 |
|
| NCI-H929 | darinaparsin | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | Dasatinib | GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| NCI-H929 | DBeQ | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Decitabine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | decitabine:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H929 | dexamethasone | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | Dihydrorotenone | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H929 | Dinaciclib | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H929 | Docetaxel | GDSC1,GDSC2 | 0.0000 | 3.0000 |
|
| NCI-H929 | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H929 | Doramapimod | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Doxorubicin | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H929 | Dyrk1b_0191 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | Eg5_9814 | GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H929 | EHT-1864 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | ELCPK | CTRP2 | 0.0000 | 0.4000 |
|
| NCI-H929 | Elephantin | GDSC2 | 0.0200 | 20.0000 |
|
| NCI-H929 | Elesclomol | GDSC1 | 0.0008 | 0.2000 |
|
| NCI-H929 | elocalcitol | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Entinostat | GDSC2,CTRP2 | 0.0100 | 33.0000 |
|
| NCI-H929 | Entospletinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | EphB4_9721 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | epigallocatechin-3-monogallate | CTRP2 | 0.0090 | 300.0000 |
|
| NCI-H929 | Epirubicin | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H929 | EPZ004777 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | EPZ5676 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | erastin | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | ERK_2440 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | ERK_6604 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | Erlotinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | etomoxir | CTRP2 | 0.0090 | 300.0000 |
|
| NCI-H929 | Etoposide | CTRP2 | 0.0009 | 28.0000 |
|
| NCI-H929 | Fedratinib | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H929 | FEN1_3940 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | FGFR_0939 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H929 | FGFR_3831 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | FGIN-1-27 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | fingolimod | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Fludarabine | GDSC2 | 0.0200 | 20.0000 |
|
| NCI-H929 | fluorouracil | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H929 | fluvastatin | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Foretinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | FQI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | FQI-2 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | FS106 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | FS112 | GDSC1 | 0.0195 | 5.0000 |
|
| NCI-H929 | FSC231 | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H929 | Fulvestrant | GDSC1,GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| NCI-H929 | fumonisin B1 | CTRP2 | 0.0150 | 500.0000 |
|
| NCI-H929 | FY012 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | FY026 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | FY069 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | Gallibiscoquinazole | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H929 | GANT-61 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | GDC-0879 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | GDC0810 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | Gefitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Gemcitabine | GDSC1,GDSC2,CTRP2 | 0.0001 | 10.0000 |
|
| NCI-H929 | glutathione | GDSC2 | 0.6403 | 640.0000 |
|
| NCI-H929 | GMX-1778 | CTRP2 | 0.0000 | 0.2900 |
|
| NCI-H929 | GNE-317 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | gossypol | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H929 | GSK-3 inhibitor IX | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | GSK-J4 | GDSC1 | 0.1172 | 30.0000 |
|
| NCI-H929 | GSK-LSD1 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H929 | GSK-LSD1-2HCl | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H929 | GSK1904529A | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | GSK2110183B | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H929 | GSK2256098C | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H929 | GSK2276186C | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | GSK2578215A | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | GSK2606414 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | GSK269962A | GDSC1 | 0.0195 | 5.0000 |
|
| NCI-H929 | GSK2801 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | GSK2830371 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | GSK2830371A | GDSC2 | 0.0030 | 10.0000 |
|
| NCI-H929 | GSK3337463A | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | GSK343 | GDSC2 | 0.0010 | 10.0000 |
|
| NCI-H929 | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | GSK461364 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | GSK591 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | GSK626616AC | GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H929 | GW441756 | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H929 | HG-5-113-01 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | HG-5-88-01 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | HKMTI-1-005 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | HLI 373 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | I-BET-762 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | I-BET151 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | I-BRD9 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | I-CBP112 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | IAP_5620 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | IAP_7638 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | Ibrutinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | IC-87114 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | ICL-SIRT078 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | ICL1100013 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H929 | Idelalisib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | ifosfamide | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | IGF1R_3801 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | IGFR_3801 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | Imatinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | indisulam | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | IOX2 | GDSC1 | 0.0004 | 0.1000 |
|
| NCI-H929 | Ipatasertib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | IRAK4_4710 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | Irinotecan | GDSC2 | 0.0050 | 10.0000 |
|
| NCI-H929 | isoevodiamine | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | isoliquiritigenin | CTRP2 | 0.0010 | 17.0000 |
|
| NCI-H929 | ISOX | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | ISOX:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| NCI-H929 | itraconazole | CTRP2 | 0.0005 | 17.0000 |
|
| NCI-H929 | IWP-2 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H929 | JAK_8517 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | JAK1_3715 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | JAK1_8709 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | JAK3_7406 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | JNK Inhibitor VIII | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H929 | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H929 | JQ1 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | JW-480 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | KHS101 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Ki8751 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Ko-143 | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H929 | KRAS (G12C) Inhibitor-12 | GDSC2 | 0.0200 | 20.0000 |
|
| NCI-H929 | KU 0060648 | CTRP2 | 0.0010 | 17.0000 |
|
| NCI-H929 | KU-0063794 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | KU-55933 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | KU-60019 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | KW-2449 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | L-685458 | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H929 | L-Oxonoreleagnine | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H929 | Lapatinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | LBH-589 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | LCL161 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | LE-135 | CTRP2 | 0.0020 | 33.0000 |
|
| NCI-H929 | Leflunomide | GDSC2 | 0.1001 | 100.0000 |
|
| NCI-H929 | Lenalidomide | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | Lenvatinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Lestaurtinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H929 | LGK974 | GDSC2 | 0.0050 | 10.0000 |
|
| NCI-H929 | Linifanib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Linsitinib | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | LJI308 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | LMB_AB1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | LMB_AB2 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | LMB_AB3 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | LMP744 | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H929 | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | lovastatin acid | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H929 | Luminespib | GDSC2 | 0.0003 | 1.0000 |
|
| NCI-H929 | LY-2183240 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | LY2109761 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | manumycin A | CTRP2 | 0.0009 | 30.0000 |
|
| NCI-H929 | Masitinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | MCT1_6447 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | MCT4_1422 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | Mdivi-1 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Merck60 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | Methotrexate | GDSC1,GDSC2,CTRP2 | 0.0008 | 66.0000 |
|
| NCI-H929 | MG-132 | GDSC2 | 0.0156 | 4.0000 |
|
| NCI-H929 | MGCD-265 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | MI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | MIM1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | MIRA-1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | Mirin | GDSC1,GDSC2 | 0.1001 | 100.0000 |
|
| NCI-H929 | mitomycin | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H929 | Mitoxantrone | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H929 | MK-0752 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | MK-1775 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | MK-2206 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | MK-8776 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H929 | ML006 | CTRP2 | 0.0160 | 530.0000 |
|
| NCI-H929 | ML030 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | ML050 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | ML162 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | ML203 | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H929 | ML210 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | ML239 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | ML258 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | ML311 | CTRP2 | 0.0010 | 66.0000 |
|
| NCI-H929 | ML312 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | ML320 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | ML323 | GDSC2 | 0.0200 | 20.0000 |
|
| NCI-H929 | MLN2238 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | MN-64 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | momelotinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Motesanib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| NCI-H929 | Mycophenolic acid | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | myricetin | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | myriocin | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | N-acetyl cysteine | GDSC2 | 2.0011 | 2000.0000 |
|
| NCI-H929 | N22899-6-C1 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | N23918-95-7 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | N24798-49-A1 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | N25720-51-A1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | N27922-53-1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | N29087-69-1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | N30652-18-1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | N9-isopropylolomoucine | CTRP2 | 0.0120 | 400.0000 |
|
| NCI-H929 | nakiterpiosin | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | narciclasine | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | Navitoclax | GDSC1,GDSC2,CTRP2 | 0.0010 | 17.0000 |
|
| NCI-H929 | navitoclax:birinapant (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H929 | necrostatin-1 | CTRP2 | 0.0160 | 530.0000 |
|
| NCI-H929 | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Nelarabine | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | neopeltolide | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | neratinib | CTRP2 | 0.0010 | 17.0000 |
|
| NCI-H929 | niclosamide | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | Nilotinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | nintedanib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Niraparib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | NPC-26 | CTRP2 | 0.0012 | 40.0000 |
|
| NCI-H929 | NSC 74859 | CTRP2 | 0.0160 | 530.0000 |
|
| NCI-H929 | NSC23766 | CTRP2 | 0.0160 | 530.0000 |
|
| NCI-H929 | NSC30930 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | NSC48300 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | NSC632839 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | NSC95397 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | NU7441 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| NCI-H929 | Nutlin-3a | GDSC1,GDSC2,CTRP2 | 0.0045 | 150.0000 |
|
| NCI-H929 | NVP-ADW742 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | NVP-TAE684 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Obatoclax Mesylate | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | OF-1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | Olaparib | GDSC1,GDSC2,CTRP2 | 0.0045 | 150.0000 |
|
| NCI-H929 | oligomycin A | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | OSI-027 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | OSI-930 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Osimertinib | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H929 | OTX015 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H929 | Oxaliplatin | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | P22077 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | PAC-1 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | Paclitaxel | GDSC2,CTRP2 | 0.0000 | 66.0000 |
|
| NCI-H929 | PAK_5339 | GDSC2 | 0.0300 | 30.0000 |
|
| NCI-H929 | Palbociclib | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| NCI-H929 | parbendazole | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | PARP_0108 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H929 | PARP_9482 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H929 | PARP_9495 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H929 | Pazopanib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | PBD-288 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H929 | PCI-34051 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | PD0325901 | GDSC1,GDSC2 | 0.0003 | 2.5000 |
|
| NCI-H929 | PD173074 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| NCI-H929 | PD318088 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | PDMP | CTRP2 | 0.0065 | 210.0000 |
|
| NCI-H929 | Pevonedistat | GDSC1,GDSC2,CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H929 | PF-184 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | PF-4708671 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | PFI-1 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | PFI3 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | PHA-793887 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | phloretin | CTRP2 | 0.0180 | 590.0000 |
|
| NCI-H929 | PI-103 | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H929 | PI3Ka_4409 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | Picolinici-acid | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | Pictilisib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | pifithrin-alpha | CTRP2 | 0.0071 | 120.0000 |
|
| NCI-H929 | pifithrin-mu | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | PIK-93 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Piperlongumine | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | PL-DI | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Platin | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | PLK_6522 | GDSC1 | 0.0024 | 0.6250 |
|
| NCI-H929 | pluripotin | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | PLX-4032 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | PLX-4720 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | Podophyllotoxin bromide | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H929 | POMHEX | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | PRIMA-1 | CTRP2 | 0.0051 | 170.0000 |
|
| NCI-H929 | PRIMA-1MET | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | PRL-3 Inhibitor I | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H929 | procarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | prochlorperazine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | PRT062607 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | purmorphamine | CTRP2 | 0.0046 | 150.0000 |
|
| NCI-H929 | PX-12 | CTRP2 | 0.0030 | 100.0000 |
|
| NCI-H929 | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Pyridostatin | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | QL-VIII-58 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | QL-XII-61 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | QS11 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | Quizartinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | RAF_9304 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | Rapamycin | GDSC2,CTRP2 | 0.0000 | 33.0000 |
|
| NCI-H929 | Refametinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | Regorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Repligen 136 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | RG-108 | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H929 | Ribociclib | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H929 | rigosertib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | RO-3306 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | Romidepsin | GDSC2 | 0.0000 | 0.0100 |
|
| NCI-H929 | rTRAIL | GDSC1 | 0.0004 | 0.1000 |
|
| NCI-H929 | Rucaparib | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H929 | Ruxolitinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | RVX-208 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | Sabutoclax | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | salermide:PLX-4032 (12:1 mol-mol) | CTRP2 | 0.0130 | 220.0000 |
|
| NCI-H929 | Sapitinib | GDSC2 | 0.0050 | 10.0000 |
|
| NCI-H929 | Saracatinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Savolitinib | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H929 | SB-225002 | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H929 | SB-431542 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | SB216763 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | SB505124 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | SB590885 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H929 | SCH-529074 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | SCH-79797 | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H929 | SCH772984 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H929 | Schweinfurthin A | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H929 | Selisistat | CTRP2 | 0.0024 | 80.0000 |
|
| NCI-H929 | Selumetinib | GDSC1,GDSC2,CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H929 | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| NCI-H929 | selumetinib:decitabine (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| NCI-H929 | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| NCI-H929 | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| NCI-H929 | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| NCI-H929 | selumetinib:navitoclax (8:1 mol-mol) | CTRP2 | 0.0730 | 150.0000 |
|
| NCI-H929 | selumetinib:piperlongumine (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| NCI-H929 | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| NCI-H929 | selumetinib:tretinoin (2:1 mol-mol) | CTRP2 | 0.0061 | 200.0000 |
|
| NCI-H929 | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| NCI-H929 | selumetinib:vorinostat (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| NCI-H929 | semagacestat | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Sepantronium bromide | GDSC2,CTRP2 | 0.0001 | 10.0000 |
|
| NCI-H929 | Serdemetan | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | serdemetan:SCH-529074 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | SGC-CBP30 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H929 | SGC0946 | GDSC1,GDSC2 | 0.0005 | 0.5000 |
|
| NCI-H929 | SGX-523 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | SID 26681509 | CTRP2 | 0.0090 | 300.0000 |
|
| NCI-H929 | sildenafil | CTRP2 | 0.0160 | 530.0000 |
|
| NCI-H929 | simvastatin | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | Sinularin | GDSC2 | 0.0030 | 3.0000 |
|
| NCI-H929 | sirolimus:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| NCI-H929 | sitagliptin | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | SJ-172550 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | SL0101 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | SMER-3 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | SN-38 | GDSC1,GDSC2,CTRP2 | 0.0000 | 1.3000 |
|
| NCI-H929 | SNS-032 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | SNX-2112 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| NCI-H929 | Sorafenib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | spautin-1 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Sphingosine Kinase 1 Inhibitor II | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | SR-II-138A | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | SR1001 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Staurosporine | GDSC2,CTRP2 | 0.0001 | 3.3000 |
|
| NCI-H929 | StemRegenin 1 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | STF-31 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | SU11274 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Sunitinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | tacrolimus | CTRP2 | 0.0023 | 74.0000 |
|
| NCI-H929 | TAF1_5496 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | Talazoparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | tamatinib | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | Tamoxifen | GDSC1,GDSC2,CTRP2 | 0.0030 | 100.0000 |
|
| NCI-H929 | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Tanespimycin | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | TANK_1366 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H929 | Taselisib | GDSC2 | 0.0040 | 10.0000 |
|
| NCI-H929 | Telomerase Inhibitor IX | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | Temozolomide | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Temsirolimus | GDSC1,GDSC2,CTRP2 | 0.0008 | 66.0000 |
|
| NCI-H929 | Teniposide | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | TG-100-115 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | TGX221 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | THR-101 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | THR-102 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | THR-103 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | tigecycline | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | tipifarnib-P1 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | tipifarnib-P2 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | Tivozanib | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | Topotecan | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | tosedostat | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H929 | TPCA-1 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Trametinib | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H929 | Tretinoin | GDSC1,CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H929 | tretinoin:carboplatin (2:1 mol-mol) | CTRP2 | 0.0030 | 100.0000 |
|
| NCI-H929 | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0025 | 83.0000 |
|
| NCI-H929 | trifluoperazine | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | triptolide | CTRP2 | 0.0000 | 0.2900 |
|
| NCI-H929 | TTK_3146 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | Tubastatin A | CTRP2 | 0.0320 | 33.0000 |
|
| NCI-H929 | TW 37 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | Ulixertinib | GDSC2 | 0.0020 | 10.0000 |
|
| NCI-H929 | ULK1_4989 | GDSC2 | 0.0300 | 30.0000 |
|
| NCI-H929 | UMI-77 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | UNC0321 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | UNC0379 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | UNC0638 | GDSC1,GDSC2 | 0.0050 | 20.0000 |
|
| NCI-H929 | UNC0642 | GDSC1 | 0.0020 | 0.5000 |
|
| NCI-H929 | UNC1215 | GDSC1 | 0.0039 | 1.0000 |
|
| NCI-H929 | Uprosertib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | valdecoxib | CTRP2 | 0.0180 | 600.0000 |
|
| NCI-H929 | vandetanib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | VE-822 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H929 | VE821 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | Veliparib | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | Venetoclax | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H929 | VER-155008 | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H929 | Vinblastine | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H929 | Vincristine | GDSC2,CTRP2 | 0.0030 | 130.0000 |
|
| NCI-H929 | Vinorelbine | GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H929 | Vismodegib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | vorapaxar | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Vorinostat | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | vorinostat:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0020 | 33.0000 |
|
| NCI-H929 | VSP34_8731 | GDSC2 | 0.0300 | 30.0000 |
|
| NCI-H929 | VTP-A | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H929 | VTP-B | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H929 | VU0155056 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | VX-11e | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | VX-702 | GDSC1 | 0.0078 | 2.0000 |
|
| NCI-H929 | WAY-362450 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | Wee1 Inhibitor | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| NCI-H929 | WEHI-539 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | WIKI4 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | Wnt-C59 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | WP1130 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | WZ4003 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | XAV939 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | XMD11-85h | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | XMD8-92 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | YK-4-279 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H929 | YL54 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H929 | zebularine | CTRP2 | 0.0180 | 590.0000 |
|
| NCI-H929 | ZG-10 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | ZL049 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | ZL109 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H929 | ZM447439 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H929 | Zoledronate | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H929 | ZSTK474 | CTRP2 | 0.0020 | 66.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC